ES-SCLC

Clinical trials for ES-SCLC explained in plain language.

Never miss a new study

Get alerted when new ES-SCLC trials appear

Sign up with your email to follow new studies for ES-SCLC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New drug combo aims to slow advanced lung cancer

Disease control Not yet recruiting

This study tests whether adding two immunotherapy drugs (iparomlimab and tuvonralimab) to standard chemotherapy and chest radiation can help people with extensive-stage small cell lung cancer live longer without their cancer growing. About 46 adults aged 18-75 who have not had pr…

Matched conditions: ES-SCLC

Phase: PHASE2 • Sponsor: The Second Affiliated Hospital of Dalian Medical University • Aim: Disease control

Last updated Jun 27, 2026 08:11 UTC

ES-SCLC

Get alerted when new ES-SCLC trials appear

New drug combo aims to slow advanced lung cancer